Australia markets closed

AstraZeneca PLC (AZN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
66.17+0.05 (+0.08%)
At close: 01:00PM EST
66.39 +0.22 (+0.33%)
After hours: 04:39PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 202.62B
Enterprise value 227.02B
Trailing P/E 103.31
Forward P/E 17.30
PEG ratio (5-yr expected) 1.29
Price/sales (ttm)4.57
Price/book (mrq)5.83
Enterprise value/revenue 5.03
Enterprise value/EBITDA 26.47

Trading information

Stock price history

Beta (5Y monthly) 0.17
52-week change 319.16%
S&P500 52-week change 3-13.51%
52-week high 371.70
52-week low 352.65
50-day moving average 358.45
200-day moving average 362.95

Share statistics

Avg vol (3-month) 36.65M
Avg vol (10-day) 35.08M
Shares outstanding 53.1B
Implied shares outstanding 6N/A
Float 83.09B
% held by insiders 10.05%
% held by institutions 117.86%
Shares short (14 Nov 2022) 44.66M
Short ratio (14 Nov 2022) 40.8
Short % of float (14 Nov 2022) 4N/A
Short % of shares outstanding (14 Nov 2022) 40.15%
Shares short (prior month 13 Oct 2022) 45.76M

Dividends & splits

Forward annual dividend rate 41.45
Forward annual dividend yield 42.19%
Trailing annual dividend rate 32.90
Trailing annual dividend yield 34.39%
5-year average dividend yield 42.99
Payout ratio 4226.56%
Dividend date 311 Sept 2022
Ex-dividend date 410 Aug 2022
Last split factor 22:1
Last split date 326 July 2015

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Sept 2022


Profit margin 4.52%
Operating margin (ttm)22.55%

Management effectiveness

Return on assets (ttm)6.32%
Return on equity (ttm)5.45%

Income statement

Revenue (ttm)45.16B
Revenue per share (ttm)14.58
Quarterly revenue growth (yoy)11.30%
Gross profit (ttm)27.61B
Net income avi to common (ttm)2.04B
Diluted EPS (ttm)0.64
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)4.52B
Total cash per share (mrq)1.46
Total debt (mrq)31.27B
Total debt/equity (mrq)88.97
Current ratio (mrq)0.81
Book value per share (mrq)11.35

Cash flow statement

Operating cash flow (ttm)8.83B
Levered free cash flow (ttm)10.39B